Shire plc

About Shire plc

Shire plc is a global biotechnology company focused on serving individuals with rare diseases and other highly specialized conditions. Founded in 1986, the company has established itself as a leader in the development of innovative therapies that address unmet medical needs.

With a commitment to research and development, Shire invests significantly in discovering new treatments that improve the quality of life for patients. The company’s portfolio includes a range of products that target various therapeutic areas, including hematology, immunology, neuroscience, and genetic disorders.

Shire’s mission is to transform the lives of patients by providing them with access to effective therapies and support. The company believes in the importance of collaboration with healthcare professionals, patients, and advocacy groups to ensure that their products meet the needs of those they serve.

• Core Values: Innovation, Integrity, and Patient-Centricity.
• Global Reach: Operating in over 100 countries worldwide.
• Employee Commitment: A diverse workforce dedicated to making a difference.

Headquartered in the UK, Shire plc continues to expand its global footprint through strategic partnerships and acquisitions. The company is dedicated to maintaining high standards of quality and compliance in all its operations.

As a pioneer in the biotechnology sector, Shire remains focused on its vision of being the leading company in rare disease treatment, ensuring that every patient has access to the therapies they need.